GLP-1 medications: what to expect in your first 8 weeks
Nausea, food noise reduction, fatigue, the "GLP-1 face" — a week-by-week guide to what's normal, what's not, and how to titrate through the rough patches.
GLP-1: what to expect in your first 8 weeks
GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) are the most impactful class of weight-management medications we have. They also have a learning curve. The first 8 weeks are when patients are most likely to either quit (because of side effects) or undershoot results (because they're not eating enough to fuel the metabolic changes happening). Both are avoidable.
Week 1: the loading dose
You start at the lowest dose (semaglutide 0.25mg weekly; tirzepatide 2.5mg weekly). This dose is not therapeutic for weight loss in most patients — it exists to let your GI tract acclimate to the medication before stepping up.
What's normal: mild nausea for 24-48 hours after injection, especially after eating fatty or large meals. Bloating. Burping. Slightly reduced appetite — you'll start to notice the absence of "food noise."
What's not normal: vomiting that doesn't stop, severe abdominal pain (particularly upper-left), inability to keep water down for more than 12 hours. Page your clinician for any of these.
Weeks 2-4: titration begins
If week 1 was tolerable, you'll typically step up to the next dose. This is when side effects often re-intensify because your body sees a higher dose of a familiar drug. The titration schedule is deliberately slow — patients who insist on jumping doses faster than recommended are the ones who quit.
Hydration is the biggest variable here. GLP-1 drugs slow gastric emptying, which means it's easy to forget to drink. Dehydration amplifies nausea, fatigue, and headaches. Aim for 80-100 oz of water daily, more if you exercise.
Weeks 4-6: the food noise lifts
Most patients notice a turning point around week 4. The constant background hum of "what's for dinner / I should snack / I'm thinking about that pastry" quiets dramatically. This isn't willpower — it's the medication acting on the central appetite-regulation circuitry.
The trap: now that you're not hungry, it becomes easy to under-eat. Going below ~1200 calories/day will tank your energy, cause muscle loss, and sabotage long-term results. The goal is a 500-750 calorie/day deficit, not a starvation regimen. Track for the first month if you've never tracked before; you'll be surprised how little you're actually eating.
Weeks 6-8: protein, protein, protein
This is the window where patients start losing significant weight. It's also when muscle loss becomes a real risk if protein intake is too low. Target 0.8-1.0 g of protein per pound of target bodyweight, not current bodyweight. Most patients on GLP-1s need to deliberately plan their protein because the medication suppresses appetite for everything, including the foods they need.
Common side effects and what to do
- Constipation: Most common in weeks 2-6. Magnesium citrate (200-400mg at night), psyllium (Metamucil), and more water usually fix it. Persistent constipation past 2 weeks: message your clinician.
- Fatigue: Usually a calorie-deficit + hydration issue. Increase fluids, ensure you're hitting protein, get B12 checked at month 3.
- "GLP-1 face": Rapid fat loss in the cheeks and temples. There's nothing pathological about it but if you don't like the look, slowing your rate of loss (smaller deficit) usually helps.
- Sulfur burps: Less of an issue with semaglutide than older GLP-1s; usually resolves with smaller meals + slower eating.
What we don't know yet
Long-term cardiovascular outcomes for newer GLP-1s look excellent, but most of the data is on people with diabetes. We're learning more every quarter about the obesity-only population, sustained weight maintenance after stopping, and the role of GLP-1s in conditions like sleep apnea, cardiovascular disease, and substance use disorders.
The honest meta-point
GLP-1s are not magic — they're a powerful appetite-regulation tool that makes lifestyle change feasible for the first time for many patients. Patients who use the medication as cover to eat 800 calories of nothing for 6 months and then stop the drug almost always regain. Patients who use the medication as an assist while they build sustainable eating, lifting, and sleep habits tend to maintain.
The medication does the appetite work. You do the lifestyle work. That's the deal.
Editorial content on a Relyv.ai demonstration site. Fictional author. Not medical advice.
Ready to start?
If you want a licensed clinician to review your case for weight loss, the intake takes about two minutes.
Start your visit